Carriers of the Prothrombin G20210A mutation, particularly those with a history of venous thrombosis, tend to exhibit increased thrombin generation, independent of plasma factor II levels, thereby significantly raising the risk of thrombus formation. The gene discussed is F2; the disease is Venous thrombosis.